Patents by Inventor Patrick Morrissey
Patrick Morrissey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11957580Abstract: A delivery device for a collapsible prosthetic heart valve, the delivery device including an inner shaft, a distal sheath disposed about a portion of the inner shaft and forming a compartment with the inner shaft, the compartment being adapted to receive the prosthetic heart valve, the inner shaft and the distal sheath being movable relative to one another, and a handle including a frame having a longitudinal axis, a proximal end and a distal end, the handle further including a deployment actuator and a hub, each of the deployment actuator and the hub being independently capable of opening and closing the compartment, the hub further including a hub actuator coupled to the inner shaft.Type: GrantFiled: November 13, 2020Date of Patent: April 16, 2024Assignee: St. Jude Medical, Cardiology Division, Inc.Inventors: Michael Shane Morrissey, Bruce Edward Frohman, Michael William Metz, Janis Paulis Skujins, David John Copeland, Spencer Patrick Brown
-
Publication number: 20240024548Abstract: A peritoneal dialysis (“PD”) system includes a housing; a PD fluid pump housed by the housing; a filter set including a filter housing and a hydrophilic filter membrane dividing an upstream chamber from a downstream chamber; a dual lumen patient line including a fresh PD fluid lumen in fluid communication with the upstream chamber and a used PD fluid lumen in fluid communication with the downstream chamber; a pressure sensor positioned and arranged to provide a pressure sensor output indicative of pressure in the downstream chamber of the filter housing; and a control unit configured to perform a pressure integrity test on the hydrophilic filter membrane by monitoring the pressure sensor output over a period of time, the pressure sensor output indicative of a negative pressure created in the downstream chamber by the PD fluid pump. A pressure drop test for evaluating the filter membrane is also disclosed.Type: ApplicationFiled: June 28, 2023Publication date: January 25, 2024Inventors: Oskar FÄLLMAN, Mauro SUFFRITTI, Björn ERICSON, Mauro GUSELLA, Michael Patrick MORRISSEY
-
Publication number: 20190388611Abstract: An infusion device for dispensing fluid at a predetermined flow rate includes an elastic bladder, a pressure regulator, and a flow restrictor. The elastic bladder includes a bladder volume portion and a bladder outlet, and the elastic bladder stores fluid in the bladder volume portion and dispenses fluid through the outlet at a bladder pressure. The pressure regulator is in fluid communication with the outlet of the elastic bladder. The pressure regulator includes a fluid inlet and a fluid outlet. The fluid inlet is coupled to the bladder outlet to receive fluid from the bladder. The flow restrictor is in fluid communication with the fluid outlet. The flow restrictor and the pressure regulator cooperate to discharge fluid from the flow restrictor at a predetermined flow rate.Type: ApplicationFiled: June 20, 2018Publication date: December 26, 2019Inventors: Dustin Christopher Cawthon, Ieng Kin Lao, Thomas Edward Dudar, Yuanpang Samuel Ding, Ying-Cheng Lo, Houzhi Luo, Michael Patrick Morrissey, Jeffrey Scott Packard
-
Patent number: 9463968Abstract: A faucet assembly for dispensing liquid from a beverage source includes a housing having a body and a cover coupled to the body. The body is configured to mount to a structure associated with the beverage source. The cover is movable relative to the body while the body is connected to the structure to provide access to an interior of the housing. The faucet assembly also includes an insert positioned within the housing in fluid communication with the beverage source to direct the liquid through the housing. The insert is removable from the housing when the cover is moved to provide access to the interior of the housing. The faucet assembly further includes an actuator supported by the housing. The actuator is movable relative to the housing to selectively inhibit fluid flow through the insert.Type: GrantFiled: October 17, 2013Date of Patent: October 11, 2016Assignee: Brewnique LLCInventors: Mark Schaefer, Patrick Morrissey, Sesha Chalapathi Madireddi, Ye Tian, Nicholas William Yurek
-
Publication number: 20140200217Abstract: The invention provides methods for modulating, e.g., antagonizing, the activity of the Hedgehog signaling pathway, and for treating Hedgehog related disorders such as cancers (e.g., medulloblastoma). In particular, the invention provides methods for inhibiting aberrant growth states resulting from phenotypes such as Ptch loss-of-function, Hedgehog gain-of-function, smoothened gain-of-function or Gli gain-of-function by administering to a mammal combinations of Smoothened inhibitors (e.g., a compound of Formula I, Formula II, or Formula III, or any of the compounds listed herein or incorporated by reference) and cholesterol biosynthesis pathway inhibitors (e.g., statins), Gli inhibitors, and/or Phosphatidylinositol 3-kinase (PI3K) inhibitors.Type: ApplicationFiled: January 24, 2014Publication date: July 17, 2014Inventors: Marion Dorsch, John E. Monahan, Michael Patrick Morrissey, Shifeng Pan, Juliet Williams
-
Patent number: 8778927Abstract: The invention provides methods for modulating, e.g., antagonizing, the activity of the Hedgehog signaling pathway, and for treating Hedgehog related disorders such as cancers (e.g., medulloblastoma). In particular, the invention provides methods for inhibiting aberrant growth states resulting from phenotypes such as Ptch loss-of-function, Hedgehog gain-of-function, smoothened gain-of-function or Gli gain-of-function by administering to a mammal combinations of Smoothened inhibitors (e.g., a compound of Formula I, Formula II, or Formula III, or any of the compounds listed herein or incorporated by reference) and cholesterol biosynthesis pathway inhibitors (e.g., statins), Gli inhibitors, and/or Phosphatidylinositol 3-kinase (PI3K) inhibitors.Type: GrantFiled: September 28, 2009Date of Patent: July 15, 2014Assignee: Novartis AGInventors: Marion Dorsch, John E. Monahan, Michael Patrick Morrissey, Shifeng Pan, Juliet Williams
-
Publication number: 20140102570Abstract: A faucet assembly for dispensing liquid from a beverage source includes a housing having a body and a cover coupled to the body. The body is configured to mount to a structure associated with the beverage source. The cover is movable relative to the body while the body is connected to the structure to provide access to an interior of the housing. The faucet assembly also includes an insert positioned within the housing in fluid communication with the beverage source to direct the liquid through the housing. The insert is removable from the housing when the cover is moved to provide access to the interior of the housing. The faucet assembly further includes an actuator supported by the housing. The actuator is movable relative to the housing to selectively inhibit fluid flow through the insert.Type: ApplicationFiled: October 17, 2013Publication date: April 17, 2014Inventors: Mark Schaefer, Patrick Morrissey, Sesha Chalapathi Madireddi, Ye Tian, Nicholas William Yurek
-
Publication number: 20140056912Abstract: The disclosure relates to methods for treating a sclerostin-expressing cancer, e.g., a squamous cell carcinoma (SCC), e.g., SCC of the upper aerodigestive tract, esophagus, or lung, employing a therapeutically effective amount of at least one sclerostin antagonist, e.g., an anti-sclerostin antibody, such as Antibody 1, 2, 3, 4 or 5.Type: ApplicationFiled: April 27, 2012Publication date: February 27, 2014Applicant: Novartis AGInventors: Seth Alexander Ettenberg, Vivien W. Chan, Michael Patrick Morrissey, David Jenkins
-
Publication number: 20110183962Abstract: The invention provides methods for modulating, e.g., antagonizing, the activity of the Hedgehog signaling pathway, and for treating Hedgehog related disorders such as cancers (e.g., medulloblastoma). In particular, the invention provides methods for inhibiting aberrant growth states resulting from phenotypes such as Ptch loss-of-function, Hedgehog gain-of-function, smoothened gain-of-function or Gli gain-of-function by administering to a mammal combinations of Smoothened inhibitors (e.g., a compound of Formula I, Formula II, or Formula III, or any of the compounds listed herein or incorporated by reference) and cholesterol biosynthesis pathway inhibitors (e.g., statins), Gli inhibitors, and/or Phosphatidylinositol 3-kinase (PI3K) inhibitors.Type: ApplicationFiled: September 28, 2009Publication date: July 28, 2011Applicant: Novartis AGInventors: Marion Dorsch, John E. Monahan, Michael Patrick Morrissey, Shifeng Pan, Juliet Williams